ArticleJTO clinical and research reports2022

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.

Wang Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.